Bispecific antibody conjugates in therapeutics
1Abbott Laboratories, Dept. 04A6, Bldg. AP8B, 100 Abbott Park Road, Abbott Park, IL 60064, USA. ying.cao@add.ssw.abbott.com
Advanced Drug Delivery Reviews
|February 5, 2003
Summary
Bispecific monoclonal antibodies (bsMAb) offer targeted therapies by binding two antigens. Their versatile structure enables drug delivery and immune response modulation for various diseases.
Area of Science:
- Immunology
- Biotechnology
- Pharmacology
Background:
- Bispecific monoclonal antibodies (bsMAb) possess a unique structure targeting two distinct antigens.
- Their dual-targeting capability allows for precise disease site localization and therapeutic agent delivery.
- bsMAb can redirect immune effector cell cytotoxicity or induce systemic anti-target immune responses.
Purpose of the Study:
- To review the therapeutic applications and production methods of bsMAb.
- To provide current clinical trial information for bsMAb therapies.
- To highlight the potential of bsMAb in addressing unmet therapeutic needs.
Main Methods:
- Literature review of scientific publications and clinical trial databases.
- Analysis of recombinant DNA technology advancements.
- Examination of genomic and immunological research findings.
Main Results:
- bsMAb can be engineered to carry various therapeutic payloads (drugs, toxins, enzymes, DNA, radionuclides).
- They show potential in redirecting immune responses and enhancing targeted cytotoxicity.
- Advancements in biotechnology and genomics facilitate the development of novel bsMAb therapies.
Conclusions:
- bsMAb represent a promising therapeutic modality with broad applicability.
- Ongoing research and clinical trials are expanding the therapeutic landscape for bsMAb.
- The unique structure and function of bsMAb position them as key players in future medicine.
Related Concept Videos
01:10Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
00:42Cross-reactivity
Overview
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:26Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...